Delivery Order SPE2DR25D1100-SPE2DR26FDD5N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on January 7, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $56.7K to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) on January 6, 2026, with completion expected by January 28, 2026. This firm fixed-price, non-set-aside contract is performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare needs,...
- The Defense Logistics Agency awarded a delivery order valued at $28,454.16 to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) on January 22, 2026, with an ultimate completion date of February 12, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating full and open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) with a completion date of February 3, 2026. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,722.86 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order was established on January 13, 2026, with an ultimate completion date of February 4, 2026. The contractor will perform from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $28,553.91 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 15, 2025, with completion expected by January 7, 2026. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $28,361.43 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) with a firm fixed-price structure. The contract is classified as a non-set-aside award, indicating it was competitively procured. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order represents a task order issued under AmerisourceBergen's parent...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $113,445.72 by the Defense Logistics Agency on January 15, 2026, for the supply of Voranigo 40 mg tablets (30-count packaging). This firm fixed-price delivery order, with an ultimate completion date of February 6, 2026, is being fulfilled from the awardee's facility in Conshohocken, Pennsylvania. The award was made on a fully competitive, non-set-aside basis, reflecting Amerisourcebergen's...
- The Defense Logistics Agency awarded a $56.9K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 10 mg tablets (30-count units) with an ultimate completion date of February 9, 2026. This competitively awarded, non-set-aside contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and...
- The Defense Logistics Agency awarded a $28.4K delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract. The order, issued on January 26, 2026, carries an ultimate completion date of February 17, 2026 and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal military and veteran healthcare systems. The...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDD5NDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $56,722.86 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on February 4, 2026, with an ultimate completion date of February 26, 2026. This firm fixed-price, non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. This strategic contract vehicle supports multiple federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.7k | 2/3/26 |